Hologic (NASDAQ: HOLX) and Lombard Medical Technologies (OTCMKTS:EVARF) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.
This table compares Hologic and Lombard Medical Technologies’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Lombard Medical Technologies||N/A||N/A||N/A|
This is a summary of current ratings and recommmendations for Hologic and Lombard Medical Technologies, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Lombard Medical Technologies||0||0||0||0||N/A|
Hologic currently has a consensus target price of $48.36, suggesting a potential upside of 29.78%. Given Hologic’s higher possible upside, equities analysts clearly believe Hologic is more favorable than Lombard Medical Technologies.
Institutional and Insider Ownership
97.6% of Hologic shares are held by institutional investors. Comparatively, 12.5% of Lombard Medical Technologies shares are held by institutional investors. 0.8% of Hologic shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Volatility and Risk
Hologic has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, Lombard Medical Technologies has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500.
Valuation and Earnings
This table compares Hologic and Lombard Medical Technologies’ top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Hologic||$3.06 billion||3.37||$755.50 million||$3.79||9.83|
|Lombard Medical Technologies||$12.17 million||0.16||-$31.03 million||($1.54)||-0.05|
Hologic has higher revenue and earnings than Lombard Medical Technologies. Lombard Medical Technologies is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.
Hologic beats Lombard Medical Technologies on 13 of the 13 factors compared between the two stocks.
Hologic Company Profile
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.
Lombard Medical Technologies Company Profile
Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company's principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees. Its products also include Altura endovascular stent graft system for the treatment of standard AAA anatomies; Aorflex delivery system for accurate placement of Aorfix in the abdominal aorta; and IntelliFlex LP delivery system that enhances the precision and control of Aorfix deployment and placement. Lombard Medical, Inc. sells its products directly through its direct sales force and distributors to state-or-government-owned hospitals. The company was founded in 2000 and is headquartered in Didcot, the United Kingdom.
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.